From: Topical gel based nanoparticles for the controlled release of oleanolic acid: design and in vivo characterization of a cubic liquid crystalline anti-inflammatory drug
No.
Formulations(mg)
Particle size
(nm) ± SD
DEE
(% w/w) ± SD
DL
Phytantriol
GMO
F127
1
90
/
10
179 ± 13.63
68.12 ± 2.36
13.04 ± 0.56
2
154 ± 11.36
59.41 ± 2.32
10.12 ± 0.43